GRACE :: Kidney Cancer

Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival

Cancer Grace ASCO 2015 - Video 01-HD


The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).

Download Transcript

Please feel free to offer comments and raise questions in our Discussion Forums.


Kidney Cancer Immunotherapy Q&A

Immunotherapy Forum Video #22: Drs. Lauren Harshman and Sumanta (Monty) Pal answer questions from the audience following their presentations on immunotherapy for kidney cancer. Moderated by Dr. Marianne Davies.

Kidney Cancer Immunotherapy: Reasons for Cautious Optimism

Immunotherapy Forum Video #21: Dr. Sumanta (Monty) Pal reviews the past, present, and future of immunotherapy for kidney cancer and expresses concern about early study results of newer treatments.

Kidney Cancer Immunotherapy: CTLA-4 & Vaccine Clinical Trials

Immunotherapy Forum Video #20: Dr. Lauren Harshman talks about clinical trials studying the CTLA-4 pathway, as well as vaccines.

Kidney Cancer Immunotherapy: PD-1 Pathway Clinical Trials

Immunotherapy Forum Video #19: Dr. Lauren Harshman discusses treating kidney cancer with immunotherapy. In this video, she focuses on clinical trials studying PD-1 and PDL-1 agents.

Ask Us, Q&A
Kidney Cancer Expert Content



Immunotherapy Patient Forum 2015 - Register Now


GRACE Cancer Video Library - Lung Cancer Videos


Immunotherapy Patient Forum 2014 Videos

Join the GRACE Faculty

Lung/Thoracic Cancer Blog
Breast Cancer Blog
Pancreatic Cancer Blog
Bladder Cancer Blog
Head/Neck Cancer Blog

Subscribe to the GRACEcast Podcast on iTunes

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
   (Free Newsletter)

Other Resources

Biomedical Learning Institute